Evidence map›Paper›PMID 23164507›Full record

ArticleJournal of neuroinflammation2012

Interleukin-1 beta-induced up-regulation of opioid receptors in the untreated and morphine-desensitized U87 MG human astrocytoma cells.

Linda Staikos Byrne, Jinsong Peng, Sraboni Sarkar, Sulie L Chang

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Linda Staikos ByrneInstitute of NeuroImmune Pharmacology, Seton Hall University, 400 South Orange Ave, South Orange, NJ 07079, USA.
Jinsong Peng
Sraboni Sarkar
Sulie L Chang
Seton Hall University · USCenters for Disease Control and Prevention · US

Funding

MORPHINE ACTIONS ON THE IMMUNE SYSTEMR01DA007058 · NIDA · SETON HALL UNIVERSITY · PI CHANG, SULIE L. · 1992 to 2011
$2.8M
Morphine Actions on the Immune SystemK02DA016149 · NIDA · SETON HALL UNIVERSITY · PI CHANG, SULIE L. · 2003 to 2012
$1.1M
Opiate's Effects on the Inflammation and Cytotoxicity in HIV-1 Transgenic RatR21DA019836 · NIDA · SETON HALL UNIVERSITY · PI CHANG, SULIE L · 2006 to 2007
$360k
NIDA NIH HHS K02 DA016149NIDA NIH HHS R01 DA07058NIDA NIH HHS R21 DA019836
6 · The paper itself

Abstract

backgroundInterleukin-1beta (IL-1β) is a pro-inflammatory cytokine that can be produced in the central nervous system during inflammatory conditions. We have previously shown that IL-1β expression is altered in the rat brain during a morphine tolerant state, indicating that this cytokine may serve as a convergent point between the immune challenge and opiate mediated biological pathways. We hypothesized that IL-1β up-regulates opioid receptors in human astrocytes in both untreated and morphine-desensitized states.

methodsTo test this hypothesis, we compared the basal expression of the mu (MOR), delta (DOR), and kappa (KOR) opioid receptors in the human U87 MG astrocytic cell line to SH-SY5Y neuronal and HL-60 immune cells using absolute quantitative real time RT-PCR (AQ-rt-RT-PCR). To demonstrate that IL-1β induced up-regulation of the MOR, DOR and KOR, U87 MG cells (2 x 105 cells/well) were treated with IL-1β (20 ng/mL or 40 ng/mL), followed by co-treatment with interleukin-1 receptor antagonist protein (IL-1RAP) (400 ng/mL or 400 ng/mL). The above experiment was repeated in the cells desensitized with morphine, where U87 MG cells were pre-treated with 100 nM morphine. The functionality of the MOR in U87 MG cells was then demonstrated using morphine inhibition of forksolin-induced intracellular cAMP, as determined by radioimmunoassay.

resultsU87 MG cells treated with IL-1β for 12 h showed a significant up-regulation of MOR and KOR. DOR expression was also elevated, although not significantly. Treatment with IL-1β also showed a significant up-regulation of the MOR in U87 MG cells desensitized with morphine. Co-treatment with IL-1β and interleukin-1 receptor antagonist protein (IL-1RAP) resulted in a significant decrease in IL-1β-mediated MOR up-regulation.

conclusionOur results indicate that the pro-inflammatory cytokine, IL-1β, affects opiate-dependent pathways by up-regulating the expression of the MOR in both untreated and morphine-desensitized U87 MG.

Indexed as

Analysis of VarianceAstrocytomaCell Line, TumorColforsinCyclic AMPDrug InteractionsGene Expression Regulation, NeoplasticHumansInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinMorphineNaloxoneNarcotic AntagonistsNarcoticsNeuroblastomaOligopeptidesColforsinCyclic AMPendomorphin 1endomorphin 2Interleukin-1betaInterleukin 1 Receptor Antagonist ProteinMorphineNaloxoneNarcotic AntagonistsNarcoticsOligopeptidesReceptors, OpioidRNA, Messenger

Identifiers

PMID23164507
PMCPMC3526549
OpenAlexW2145408508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.